This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Molina, A. R. Articles by Lacal, J. C. Search for Related Content PubMed PubMed Citation Articles by de Molina, A. R. Articles by Lacal, J. C.

Choline Kinase Activation Is a Critical Requirement for the Proliferation of Primary Human Mammary Epithelial Cells and Breast Tumor Progression

¹ Department of Molecular and Cellular Biology of Cancer, Translational Oncology Unit, Instituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Cicutíficas, Madrid, Spain; and ² Confocal Service, Interdepartment Research Service (Sidi), Universidad Autónoma de Madrid, Madrid, Spain

Breast cancer is still one of the most important tumors among women in industrialized countries. Improvement in both understanding the molecular events associated with the disease and the development of new additional treatments is still an important goal to be achieved. Choline kinase (ChoK) is increased in human mammary tumors with high incidence, and this activation is associated with clinical variable indicators of greater malignancy. Here, we have investigated the role of ChoK in the development of breast cancer and found that ChoK is both necessary and sufficient for growth factor-induced proliferation in primary human mammary epithelial cells and an absolute requirement for the specific mitogenic response to heregulin in breast tumor-derived cells. These results demonstrate that ChoK plays an essential role in both normal human mammary epithelial cell proliferation and breast tumor progression. Furthermore, inhibition of ChoK shows a strong in vivo antitumor activity against human breast cancer xenografts. Thus, ChoK constitutes a novel bona fide molecular target for the treatment of breast cancer patients.

This article has been cited by other articles:

				K. B. Contractor, L. M. Kenny, J. Stebbing, A. Al-Nahhas, C. Palmieri, D. Sinnett, J. S. Lewis, K. Hogben, S. Osman, S. Shousha, et al. [11C]Choline Positron Emission Tomography in Estrogen Receptor-Positive Breast Cancer Clin. Cancer Res., September 1, 2009; 15(17): 5503 - 5510. [Abstract] [Full Text] [PDF]

				C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF]

				K. Glunde, T. Shah, P. T. Winnard Jr., V. Raman, T. Takagi, F. Vesuna, D. Artemov, and Z. M. Bhujwalla Hypoxia Regulates Choline Kinase Expression through Hypoxia-Inducible Factor-1{alpha} Signaling in a Human Prostate Cancer Model Cancer Res., January 1, 2008; 68(1): 172 - 180. [Abstract] [Full Text] [PDF]

				N. Mori, K. Glunde, T. Takagi, V. Raman, and Z. M. Bhujwalla Choline Kinase Down-regulation Increases the Effect of 5-Fluorouracil in Breast Cancer Cells Cancer Res., December 1, 2007; 67(23): 11284 - 11290. [Abstract] [Full Text] [PDF]

				J. G. Bundy, N. G. Iyer, M. S. Gentile, D.-E. Hu, M. Kettunen, A.-T. Maia, N. P. Thorne, J. D. Brenton, C. Caldas, and K. M. Brindle Metabolic Consequences of p300 Gene Deletion in Human Colon Cancer Cells. Cancer Res., August 1, 2006; 66(15): 7606 - 7614. [Abstract] [Full Text] [PDF]

				M. Katzenellenbogen, O. Pappo, H. Barash, N. Klopstock, L. Mizrahi, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, L. A. Mitchell, et al. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the mdr2-knockout mice. Cancer Res., April 15, 2006; 66(8): 4001 - 4010. [Abstract] [Full Text] [PDF]

				N. M.S. Al-Saffar, H. Troy, A. R. de Molina, L. E. Jackson, B. Madhu, J. R. Griffiths, M. O. Leach, P. Workman, J. C. Lacal, I. R. Judson, et al. Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Choline Kinase Inhibitor MN58b in Human Carcinoma Models Cancer Res., January 1, 2006; 66(1): 427 - 434. [Abstract] [Full Text] [PDF]

				K. Glunde, V. Raman, N. Mori, and Z. M. Bhujwalla RNA Interference-Mediated Choline Kinase Suppression in Breast Cancer Cells Induces Differentiation and Reduces Proliferation Cancer Res., December 1, 2005; 65(23): 11034 - 11043. [Abstract] [Full Text] [PDF]

				A. Ramirez de Molina, D. Gallego-Ortega, J. Sarmentero, M. Banez-Coronel, Y. Martin-Cantalejo, and J. C. Lacal Choline Kinase Is a Novel Oncogene that Potentiates RhoA-Induced Carcinogenesis Cancer Res., July 1, 2005; 65(13): 5647 - 5653. [Abstract] [Full Text] [PDF]

				M. Beloueche-Babari, L. E. Jackson, N. M.S. Al-Saffar, P. Workman, M. O. Leach, and S. M. Ronen Magnetic Resonance Spectroscopy Monitoring of Mitogen-Activated Protein Kinase Signaling Inhibition Cancer Res., April 15, 2005; 65(8): 3356 - 3363. [Abstract] [Full Text] [PDF]